Varenicline
|
 |
Molecular structure via molpic |
|
Conformer structure via 3Dmol.js |
Molecular formula | C13H13N3[1] |
---|
Molecular mass | 211.26 g/mol[1] |
---|
Predicted LogP | 0.8[1] |
---|
Decomposition | Hazardous decomposition products: Hazardous decomposition products formed under fire conditions. - Carbon oxides, nitrogen oxides (NOx)[1] |
---|
Identifiers [] |
IUPAC name | 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]hexadeca-2,4,6,8,10-pentaene[1] |
---|
SMILES | C1C2CNCC1C3=CC4=NC=CN=C4C=C23[1] |
---|
InChI | InChI=1S/C13H13N3/c1-2-16-13-5-11-9-3-8(6-14-7-9)10(11)4-12(13)15-1/h1-2,4-5,8-9,14H,3,6-7H2[1] |
---|
InChIKey | JQSHBVHOMNKWFT-UHFFFAOYSA-N[1] |
---|
Dosing |
Elimination half-life | 24 hours |
---|
Varenicline
Varenicline (also known as Ncgc00247735-01, Ncgc00247735-02, Vareniclin, Varenicline?, CP 526555; Champix; Chantix, s6985, CS-0396, DB01273, SB17430 or Ncgc00247735-03)
Legal status
- Canada: Varenicline is a prescription only substance.
- United Kingdom: Varenicline is a prescription only substance.
- United States: Varenicline is a prescription only substance.
- European Union: Varenicline is a prescription only substance.
See also
External links